New hope for AIDS patients in the vaccine

A new HIV vaccine has shown promising results in primary tests on humans and monkeys, prompting scientists to be optimistic about its effectiveness.

Scientists studied the effects of the vaccine on 393 people tested in 12 HIV clinics in East Africa, South Korea, Thailand and the United States.

The study, published in the medical journal Lancet, reported on the response of all vaccine recipients by producing a form of immune response to HIV during the trial

. Separate vaccine on rhesus macaque monkeys, h [67,9002] As these tests are successful, the second phase of trials is currently underway for 2,600 women in Africa and sub-Saharan Africa.

Dan Baroche said: "We must recognize that the development of the HIV vaccine is an unprecedented challenge, but its success in protecting two-thirds of the monkeys in a hands-on experience does not mean that it's going to to protect humans, so we must wait for the results of the study before knowing whether it will protect humans or not. "

It is believed that about 37 million people in the world are living with HIV or AIDS, Of which more than 2 million children According to the Joint United Nations Program on HIV / AIDS (UNAIDS), about 1.8 million people worldwide are infected each year. Nobody, about 5,000 new cases every day.